A theory of the cancer age-specific incidence data based on extreme value distributions
Source abstract
Abstract
The incidence of cancers varies with age, if normalized this is called the age-specific incidence. A mathematical model that describes this variation should provide a better understanding of how cancers develop. We suggest that the age-specific incidence should follow an extreme value distribution, based on three widely accepted assumptions: (1) a tumor develops from a single cell, (2) many potential tumor progenitor cells exist in a tissue, and (3) cancer is diagnosed when the first of these many potential tumor cells develops into a tumor. We tested this by comparing the predicted distribution to the age-specific incidence data for colon and prostate carcinomas collected by the Surveillance, Epidemiology and End Results network of 17 cancer registries. We found that colon carcinoma age-specific incidence data is consistent with an extreme value distribution, while prostate carcinomas age-specific incidence data generally follows the distribution. This model indicates that both colon and prostate carcinomas only occur in a subset of the population (22% for prostate and 13.5% for colon.) Because of their very general nature, extreme value distributions might be applicable to understanding other chronic human diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Liver Disease Diagnosis and Treatment · Pancreatic and Hepatic Oncology Research · Cancer Genomics and Diagnostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
University of California–Irvine Department of Biomedical Engineering, Center for Complex Biological Systems, , Irvine, California 92697-2715, USA
References (24)
Show source-provided references
1. Cell · 2000 · 100 · 5710.1016/S0092-8674(00)81683-9 ↗
2. Cell · 2011 · 144 · 64610.1016/j.cell.2011.02.013 ↗
3. Trends Genet · 1993 · 9 · 13810.1016/0168-9525(93)90209-Z ↗
4. Science · 1987 · 238 · 19310.1126/science.2889267 ↗
5. Nature · 2001 · 414 · 10510.1038/35102167 ↗
6. J Natl Cancer Inst · 2011 · 103 · 71410.1093/jnci/djr077 ↗
7. Br J Cancer · 1954 · 8 · 110.1038/bjc.1954.1 ↗
8. Br J Cancer · 2004 · 91 · 198310.1038/sj.bjc.6602297 ↗
9. Cancer Res · 1984 · 44 · 4217
10. Br J Cancer · 1957 · 11 · 16110.1038/bjc.1957.22 ↗
11. Int J Epidemiol · 2004 · 33 · 118210.1093/ije/dyh288 ↗
12. Proc Natl Acad Sci U S A · 2008 · 105 · 1628410.1073/pnas.0801151105 ↗
13. Cancer Inform · 2010 · 9 · 179
14. 2007
15. Curr Biol · 2004 · 14 · 24210.1016/S0960-9822(03)00937-0 ↗
16. Cancer Res · 2008 · 68 · 446510.1158/0008-5472.CAN-07-1670 ↗
17. Toxicol Ind Health · 2003 · 19 · 12510.1191/0748233703th195oa ↗
18. Toxicol Ind Health · 2002 · 18 · 36510.1191/0748233702th164oa ↗
19. Breast Cancer Res Treat · 2005 · 91 · 12110.1007/s10549-004-5782-y ↗
20. Proc. Cambridge Phil. Soc. · 1928 · 24 · 18010.1017/S0305004100015681 ↗
21. Seer*stat database: Incidence - seer 17
22. ACM Transactions on Mathematical Software · 1978 · 4 · 3410.1145/355769.355773 ↗
23. Ann Intern Med · 2002 · 137 · 12910.7326/0003-4819-137-2-200207160-00014 ↗
24. Ann Intern Med · 2008 · 149 · 62710.7326/0003-4819-149-9-200811040-00243 ↗